Isabel Verduyn van Weegen - 17 Feb 2026 Form 4 Insider Report for Evommune, Inc. (EVMN)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: EVMN
Reported as of: 17 Feb 2026
Net transaction value: +$9,999,998
SEC form: 4
Accepted by SEC: 18 Feb 2026, 21:19:40 UTC
Prior SEC filing: 12 Nov 2025
Next SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Gregory S. Moss, Attorney-in-Fact

Key filing fact

Isabel Verduyn van Weegen filed Form 4 for Evommune, Inc. (EVMN) on 18 Feb 2026.

Key facts

This page summarizes Isabel Verduyn van Weegen's Form 4 filing for Evommune, Inc. (EVMN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Feb 2026, 21:19.

Change

Previous filing in this sequence was filed on 12 Nov 2025.
Current net transaction value: +$9,999,998.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002094941 Primary reporting owner

Verduyn-van Weegen Felice Isabel

Relationship: Director, 10%+ Owner
Address: C/O EVOMMUNE, INC., 1841 PAGE MILL ROAD, SUITE 100, PALO ALTO
Signature: /s/ Gregory S. Moss, Attorney-in-Fact
Signature date: 18 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVMN transaction

Common Stock

Award

Transaction value: $9,999,998
Shares: +358,680
Change %: +7.3%
Price: $27.88
Shares after: 5,288,313
Date: 17 Feb 2026
Ownership: By LSP 7 Cooperatief U.A.
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These securities are held by LSP 7 Cooperatief U.A. ("LSP 7"). LSP 7 Management BV ("LSP 7 Management") may be deemed to beneficially own these securities. As managing directors of LSP 7 Management, each of Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may also be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest, if any, therein.